Literature DB >> 31891015

Neurodegeneration: The emerging non-coding connections.

Dipen Rajgor1,2, Emanuele Buratti2.   

Abstract

Entities:  

Keywords:  Neurodegeneration; Non-coding RNA

Year:  2019        PMID: 31891015      PMCID: PMC6926175          DOI: 10.1016/j.ncrna.2019.09.002

Source DB:  PubMed          Journal:  Noncoding RNA Res        ISSN: 2468-0540


× No keyword cloud information.
Neurodegenerative diseases comprise a wide class of pathological disorders, including Alzheimer's, Parkinson's and Huntington's diseases, spinocerebellar ataxia (SCA), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS). ncRNAs in the form of long ncRNAs (lncRNAs), circular RNAs (circRNAs) and microRNAs (miRNAs) are abundantly expressed in the central nervous system. Protein-coding genes occupy less than 2% of the genome, yet they are heavily studied in neurological function. In comparison, the role of ncRNAs have only attracted a small degree of attention. However, over recent years there has been a significant outpour in the number of studies demonstrating the important roles played by ncRNAs in brain development, function, plasticity and disease. In this special issue entitled ‘Neurodegeneration: The Emerging Non-coding Connections’ we have gathered a number of important reviews which highlight recent advances for the role of ncRNAs in neurodegenerative diseases. Gagliardi et al. and Andrew Douglas discuss the role of ncRNAs in ALS [1,2]; highlighting the complex roles these classes of RNAs play in ALS and how much work is still required for understating how they contribute to the pathological nature of ALS. Tatyana Shelkovnikova and colleges outline novel roles for nuclear paraspeckles in neurodegeneration [3]. Duncan Ayers and Charles Scerri provide an extensive review of the role of ncRNAs in dementia [4], while Dipen Rajgor provides an overview of miRNAs in neurodegeneration [5]. Maria Paola Paronetto and colleges describe therapeutic interventions miRNAs may play in treating motor neuron diseases [6]. Shobana Sekar and Winnie Liang describe the roles of circRNAs in brain function and how these are tied to neurodegenerative diseases [7]. Together, these reviews provide a compelling overview of the mechanistic roles played by ncRNAs in neurodegenerative disorders and how they can be potentially targeted to therapeutically treat diseases involving pathology associated with the central nervous system.
  7 in total

Review 1.  Macro roles for microRNAs in neurodegenerative diseases.

Authors:  Dipen Rajgor
Journal:  Noncoding RNA Res       Date:  2018-07-31

Review 2.  NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found?

Authors:  Haiyan An; Non G Williams; Tatyana A Shelkovnikova
Journal:  Noncoding RNA Res       Date:  2018-11-15

Review 3.  Non-coding RNA in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction.

Authors:  Andrew G L Douglas
Journal:  Noncoding RNA Res       Date:  2018-09-10

Review 4.  Non-coding RNA influences in dementia.

Authors:  Duncan Ayers; Charles Scerri
Journal:  Noncoding RNA Res       Date:  2018-09-29

Review 5.  Long non coding RNAs and ALS: Still much to do.

Authors:  Stella Gagliardi; Cecilia Pandini; Maria Garofalo; Matteo Bordoni; Orietta Pansarasa; Cristina Cereda
Journal:  Noncoding RNA Res       Date:  2018-11-15

Review 6.  Circular RNA expression and function in the brain.

Authors:  Shobana Sekar; Winnie S Liang
Journal:  Noncoding RNA Res       Date:  2019-01-05

Review 7.  Dysregulation of microRNA metabolism in motor neuron diseases: Novel biomarkers and potential therapeutics.

Authors:  Elisa De Paola; Veronica Verdile; Maria Paola Paronetto
Journal:  Noncoding RNA Res       Date:  2018-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.